Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-BROMFENAC DIN 02537788

Status: Marketed
Holder: APOTEX INC
Molecule: BROMFENAC (BROMFENAC SODIUM SESQUIHYDRATE)
Available to quote

Health Canada record

Active ingredient(s)BROMFENAC (BROMFENAC SODIUM SESQUIHYDRATE) 0.07 %
Dosage formSolution
RouteOphthalmic
SchedulePRESCRIPTION
ClassHuman
ATCS01BC11 BROMFENAC
Original market date12-Jun-2023
Current status date12-Jun-2023
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing BROMFENAC (BROMFENAC SODIUM SESQUIHYDRATE)

DINProductCompanyFormStrengthStatus
02540789AURO-BROMFENACAURO PHARMA INCSolutionBROMFENAC (BROMFENAC SODIUM SESQUIHYDRATE) 0.07 %Marketed
02548259EUGIA-BROMFENACEUGIA PHARMA INC.SolutionBROMFENAC (BROMFENAC SODIUM SESQUIHYDRATE) 0.07 %Approved
02439123PROLENSABAUSCH & LOMB INCSolutionBROMFENAC (BROMFENAC SODIUM SESQUIHYDRATE) 0.07 %Marketed

Notices of Compliance

NOCDateSubmissionReason
306332023-05-04Abbreviated New Drug Submission (ANDS)
Request a quote for APO-BROMFENAC

How to read a Canadian DIN record